The Miami Entrepreneur

: Black patients were rarely included in clinical trials — until the COVID-19 vaccines. What happens next?

Read Time:6 Second

Corporations and regulators appear to have similar goals when it comes to making clinical trials representative of the U.S. population.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post Market Snapshot: Wall Street on course to continue its rotten run, with ISM manufacturing data in focus
Next post Need to Know: Here’s what investor says he’s learned from Warren Buffett and Charlie Munger — and the mistakes he’s made